Sign up for our newsletter

A new type of blood test for breast cancer could help avoid thousands of unnecessary surgeries and otherwise precisely monitor disease progression.

While family history has previously been associated with the risk of Alzheimer’s, this is the first study of its kind that in these numbers indicate.

While the sequencing of hundreds of thousands of human cancer genomes has driven the transformational development of precise targeted cancer treatment.

Whether you use the word biotechnology, bioscience or one of a number of related words—the lines are quickly blurring—“bio” in Arizona has mad.

By replacing atoms in chemical compounds with radioactive alternatives, Scientists have discovered countless medical applications, from helping to dis.

If “sandbox” and “blockchain” are new terms for you, they won’t be after reading this issue of TechConnect. As you’ll learn inside, public.

The future is really about alternatives. More specifically, that means renewable energy. And that's not just me talking..

Sign up for our newsletter

  • About TechConnect

    TechConnect is a partnership between the Arizona Technology Council and Arizona Commerce Authority Opens in New Window.

    View the TechConnect Spring 2020 edition in its entirety: Risk Capital

    Since 2005, TechConnect has been dedicated to covering innovation and technology in Arizona and beyond. It provides news and analysis about the region’s leading companies, emerging companies (and their technologies) as well as the latest industry trends and critical issues that are propelling Arizona’s technology ecosystem.

    Read More
  • ©2020 Arizona Technology Council. | Terms | Privacy Policy | Powered by SocialSEO | Designed and Managed by KEO Marketing | XML Sitemap | HTML Sitemap